SCHEMBL9998618

SCHEMBL9998618

CC(=O)OC/C(C)=C/c1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.46
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
USP2 O75604 1/20 0.44
HPGD P15428 1/20 0.44
TRPA1 O75762 1/20 0.42
PTGS2 P35354 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
CACNA1B Q00975 1/20 0.40
ALDH1A1 P00352 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998619 1.00 CYP2C9 (0.46) CYP2C9HDAC3HDAC4HDAC1HDAC7
SCHEMBL9998157 0.84 LMNA (0.41) CYP2C9SMN1; SMN2CACNA1BALDH1A1CYP1A2
SCHEMBL9998159 0.84 LMNA (0.41) CYP2C9SMN1; SMN2CACNA1BALDH1A1CYP1A2
SCHEMBL9998548 0.83 KDM4E (0.44) HPGDSMN1; SMN2ALDH1A1L3MBTL1HTT
SCHEMBL9998139 0.83 MAPT (0.53) CYP2C9TRPA1ALDH1A1L3MBTL1CYP1A2
SCHEMBL9997740 0.83 LMNA (0.53) CYP2C9HPGDPTGS2SMN1; SMN2ALDH1A1
SCHEMBL9997743 0.83 LMNA (0.53) CYP2C9HPGDPTGS2SMN1; SMN2ALDH1A1
SCHEMBL9998137 0.83 MAPT (0.53) CYP2C9TRPA1ALDH1A1L3MBTL1CYP1A2
SCHEMBL5454170 0.82 MEN1 (0.51) HPGDSMN1; SMN2CACNA1BALDH1A1GRIK1
SCHEMBL5454169 0.82 MEN1 (0.51) HPGDSMN1; SMN2CACNA1BALDH1A1GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP2C9 28/4885HDAC3 1408/4885HDAC4 2865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.